Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anaplerotic therapy of huntington disease and other polyglutamine diseases

Anaplerotic therapy of huntington disease and other polyglutamine diseases

US Patent 9717705 · Granted Aug 1, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of gangliosides metabolism for the treatment of motor neuron diseases2021
Anaplerotic therapy of huntington disease and other polyglutamine diseases2019
Anaplerotic therapy of huntington disease and other polyglutamine diseases2019
Triheptanoin for the treatment of glucose transport 1 deficiency2018
Urinary triaosylceramide (Gb3) as a marker of cardiac disease2017
Triheptanoin for the treatment of glucose transport 1 deficiency2016
Urinary triaosylceramide (GB3) as a marker of cardiac disease2015